全文获取类型
收费全文 | 3138篇 |
免费 | 211篇 |
国内免费 | 21篇 |
专业分类
耳鼻咽喉 | 33篇 |
儿科学 | 101篇 |
妇产科学 | 60篇 |
基础医学 | 461篇 |
口腔科学 | 33篇 |
临床医学 | 340篇 |
内科学 | 647篇 |
皮肤病学 | 21篇 |
神经病学 | 253篇 |
特种医学 | 176篇 |
外科学 | 598篇 |
综合类 | 26篇 |
现状与发展 | 1篇 |
预防医学 | 177篇 |
眼科学 | 45篇 |
药学 | 177篇 |
中国医学 | 3篇 |
肿瘤学 | 218篇 |
出版年
2023年 | 13篇 |
2022年 | 27篇 |
2021年 | 62篇 |
2020年 | 41篇 |
2019年 | 68篇 |
2018年 | 75篇 |
2017年 | 66篇 |
2016年 | 70篇 |
2015年 | 99篇 |
2014年 | 120篇 |
2013年 | 164篇 |
2012年 | 258篇 |
2011年 | 255篇 |
2010年 | 142篇 |
2009年 | 138篇 |
2008年 | 233篇 |
2007年 | 221篇 |
2006年 | 193篇 |
2005年 | 212篇 |
2004年 | 181篇 |
2003年 | 164篇 |
2002年 | 177篇 |
2001年 | 22篇 |
2000年 | 15篇 |
1999年 | 15篇 |
1998年 | 33篇 |
1997年 | 16篇 |
1996年 | 8篇 |
1995年 | 20篇 |
1994年 | 21篇 |
1993年 | 16篇 |
1992年 | 16篇 |
1991年 | 7篇 |
1990年 | 7篇 |
1989年 | 8篇 |
1988年 | 10篇 |
1987年 | 9篇 |
1986年 | 9篇 |
1985年 | 10篇 |
1984年 | 10篇 |
1983年 | 8篇 |
1982年 | 16篇 |
1981年 | 10篇 |
1980年 | 14篇 |
1979年 | 9篇 |
1978年 | 8篇 |
1977年 | 6篇 |
1976年 | 6篇 |
1974年 | 6篇 |
1961年 | 5篇 |
排序方式: 共有3370条查询结果,搜索用时 15 毫秒
101.
Ostermann M Chang R 《Critical care medicine》2007,35(11):2669; author reply 2669-2669; author reply 2670
102.
Lavu Vamsi Gutknecht Norbert Vasudevan Amrutha S.K Balaji Hilgers Ralf-Dieter Franzen Rene 《Lasers in medical science》2022,37(3):1625-1634
Lasers in Medical Science - The objective of this prospective randomized controlled single-center clinical trial was to prove the efficacy of adjunctive photobiomodulation in improving selected... 相似文献
103.
104.
Paulina Krzyszczyk Hwan June Kang Suneel Kumar Yixin Meng Maurice D. O'Reggio Kishan Patel Ivan S. Pires Martin L. Yarmush Rene S. Schloss Andre F. Palmer Franois Berthiaume 《Wound repair and regeneration》2020,28(4):493-505
Nonhealing wounds possess elevated numbers of pro‐inflammatory M1 macrophages, which fail to transition to anti‐inflammatory M2 phenotypes that promote healing. Hemoglobin (Hb) and haptoglobin (Hp) proteins, when complexed (Hb‐Hp), can elicit M2‐like macrophages through the heme oxygenase‐1 (HO‐1) pathway. Despite the fact that nonhealing wounds are chronically inflamed, previous studies have focused on non‐inflammatory systems, and do not thoroughly compare the effects of complexed vs individual proteins. We aimed to investigate the effect of Hb/Hp treatments on macrophage phenotype in an inflammatory, lipopolysaccharide (LPS)‐stimulated environment, similar to chronic wounds. Human M1 macrophages were cultured in vitro and stimulated with LPS. Concurrently, Hp, Hb, or Hb‐Hp complexes were delivered. The next day, 27 proteins related to inflammation were measured in the supernatants. Hp treatment decreased a majority of inflammatory factors, Hb increased many, and Hb‐Hp had intermediate trends, indicating that Hp attenuated overall inflammation to the greatest extent. From this data, Ingenuity Pathway Analysis software identified high motility group box 1 (HMGB1) as a key canonical pathway—strongly down‐regulated from Hp, strongly up‐regulated from Hb, and slightly activated from Hb‐Hp. HMGB1 measurements in macrophage supernatants confirmed this trend. In vivo results in diabetic mice with biopsy punch wounds demonstrated accelerated wound closure with Hp treatment, and delayed wound closure with Hb treatment. This work specifically studied Hb/Hp effects on macrophages in a highly inflammatory environment relevant to chronic wound healing. Results show that Hp—and not Hb‐Hp, which is known to be superior in noninflammatory conditions—reduces inflammation in LPS‐stimulated macrophages, and HMGB1 signaling is also implicated. Overall, Hp treatment on M1 macrophages in vitro reduced the inflammatory secretion profile, and also exhibited benefits in in silico and in vivo wound‐healing models. 相似文献
105.
Jacqueline M. Smits Jens Gottlieb Erik Verschuuren Patrick Evrard Rogier Hoek Christiane Knoop György Lang Johanna M. Kwakkel-van Erp Robin Vos Geert Verleden Benoit Rondelet Daniel Hoefer Frank Langer Rene Schramm Konrad Hoetzenecker Diana van Kessel Bart Luijk Leonard Seghers Tobias Deuse Roland Buhl Christian Witt Agita Strelniece Dave Green Erwin de Vries Guenter Laufer Dirk Van Raemdonck 《Transplant international》2020,33(5):544-554
The aim of this study was to investigate whether there is an impact of donation rates on the quality of lungs used for transplantation and whether donor lung quality affects post-transplant outcome in the current Lung Allocation Score era. All consecutive adult LTx performed in Eurotransplant (ET) between January 2012 and December 2016 were included (N = 3053). Donors used for LTx in countries with high donation rate were younger (42% vs. 33% ≤45 years, P < 0.0001), were less often smokers (35% vs. 46%, P < 0.0001), had more often clear chest X-rays (82% vs. 72%, P < 0.0001), had better donor oxygenation ratios (20% vs. 26% with PaO2/FiO2 ≤ 300 mmHg, P < 0.0001), and had better lung donor score values (LDS; 28% vs. 17% with LDS = 6, P < 0.0001) compared with donors used for LTx in countries with low donation rate. Survival rates for the groups LDS = 6 and ≥7 at 5 years were 69.7% and 60.9% (P = 0.007). Lung donor quality significantly impacts on long-term patient survival. Countries with a low donation rate are more oriented to using donor lungs with a lesser quality compared to countries with a high donation rate. Instead of further stretching donor eligibility criteria, the full potential of the donor pool should be realized. 相似文献
106.
107.
Eyitayo O. Owolabi RN PhD Samukelisiwe Nyamathe MBChB Conran Joseph PhD Lee-Ann Jacobs-Nzuzi Khuabi PhD Rene G. English MBChB MMed FCPHM PhD Adriaan Vlok MBChB FC MMed PhD Elaine Erasmus FCEM MMed EM DipPEC MBChB Heike I. Geduld MBChB FCEM MMed Hendrick J. Lategan BSc MBBCh MMed FCEM Kathryn M. Chu MD MPH FACS FASCRS 《Journal of evaluation in clinical practice》2023,29(2):380-391
108.
Sascha A. Müller MD Arianeb Mehrabi MD Nuh N. Rahbari MD Rene Warschkow MD Heike Elbers MD Christine Leowardi MD Hamidreza Fonouni MD Ignazio Tarantino MD MSc Peter Schemmer MD Bruno M. Schmied MD Markus W. Büchler MD 《Annals of surgical oncology》2014,21(1):155-164
Purpose
To assess the impact of perioperative blood transfusion on overall and disease-free survival in patients undergoing curative resection for cholangiocarcinoma.Methods
In a single-center study, 128 patients undergoing curative resection for cholangiocarcinoma between 2001 and 2010 were assessed. The median follow-up period was 19 months. Transfused and nontransfused patients were compared by Cox regression and propensity score analyses.Results
Overall, 38 patients (29.7 %) received blood transfusions. The patient characteristics were highly biased with respect to receiving transfusions (propensity score 0.69 ± 0.22 vs. 0.11 ± 0.16, p < 0.001). In the unadjusted analysis, blood transfusion was associated with a 105 % increased risk of mortality [hazard ratio (HR) 2.05, 95 % CI 1.19–3.51, p = 0.010]. In the multivariate (HR 1.14, 95 % CI 0.52–2.48, p = 0.745) and the propensity score-adjusted Cox regression (HR 1.02, 95 % CI 0.39–2.62, p = 0.974), blood transfusion had no influence on overall survival. Similarly, in the propensity score-adjusted Cox regression (HR 0.62, 95 % CI 0.24–1.58, p = 0.295), no relevant effect of blood transfusion on disease-free survival was observed.Conclusions
To our knowledge, this is the first propensity score-based analysis providing compelling evidence that the worse oncological outcome after curative resection for advanced cholangiocarcinoma in patients receiving perioperative blood transfusions is caused by the clinical circumstances requiring the transfusions, not by the blood transfusions themselves. 相似文献109.
Ebo D. de Muinck Paolo Angelini Kathy Dougherty Bart J. Verkerke Gerhard Rakhorst Rene B. van Dijk Kong I. Lie 《Catheterization and cardiovascular interventions》1993,30(1):58-62
The effective flow rates with human blood through an autoperfusion catheter cannot be monitored in vivo and have not been experimentally determined in vitro. The manufacturers (Advanced Cardiovascular Systems [ACS], Temecula, CA) have suggested that “the flow rate” through the Stack over the wire and the RX-60 monorail catheter is 60 ml/min with a pressure gradient of 80 mmHg. We measured human blood flow rates in vitro through these catheters under different continuous pressure regimens (between 40 and 120 mmHg), with varying hematocrit levels (between 25% and 62%). Measured blood flows at a gradient of 80 mmHg were found to vary from 32 to 65 cc/min, with hematocrit levels of 62-25%. Minor variations in the circuitry, besides the viscosity of the medium, cause significant changes in observed flow rates (such as kinking of the catheter and blood sedimentation). In vitro determinations of blood flows cannot automatically be transferred to the in vivo condition, primarily because in vitro determinations do not account for the systolic intramural pressure increase (which may overcome the aortic pressure). If such a phenomenon is also considered, then the in vitro flow rates reported here should be multiplied by a factor of 0.40–0.60 to determine effective in vivo flow rates. Such information is relevant for the clinical operator of angioplasty, especially in the treatment of patients at high risk for undergoing percutaneous transluminal coronary angioplasty. © 1993 Wiiey-Liss, Inc. 相似文献
110.
Metzger ML Howard SC Fu LC Peña A Stefan R Hancock ML Zhang Z Pui CH Wilimas J Ribeiro RC 《Lancet》2003,362(9385):706-708
The causes of treatment failure in childhood acute lymphoblastic leukaemia are thought to differ between resource-rich and resource-poor countries. We assessed the records of 168 patients treated for this disease in Honduras. Abandonment of treatment (n=38), the main cause of failure, was associated with prolonged travel time to the treatment facility (2-5 h: hazard ratio 3.1, 95% CI 1.2-8.1 vs >5 h: 3.7, 1.3-10.9) and age younger than 4.5 years (2.6, 1.1-6.3). 35 patients died of treatment-related effects. Outcome could be substantially improved by interventions that help to prevent abandonment of therapy (such as funding for transport, satellite clinics, and support groups), and by prompt treatment of infection. 相似文献